Can both nicorandil and nitroglycerin be used together in a patient with chronic stable angina?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Both Nicorandil and Nitroglycerin Be Used Together in Chronic Stable Angina?

Yes, nicorandil and nitroglycerin can be used together in patients with chronic stable angina, as they have complementary mechanisms of action and this combination is explicitly supported by current guidelines for patients with inadequate symptom control on first-line therapy.

Rationale for Combined Use

The combination is pharmacologically sound because these agents work through different mechanisms:

  • Nitroglycerin acts primarily as a nitric oxide donor, causing venous pooling (reducing preload) and dilating epicardial coronary arteries 1, 2
  • Nicorandil has dual action: it functions both as a nitrate (NO donor) AND as an ATP-sensitive potassium channel opener, providing more balanced arterial and venous vasodilation 3, 4

Research directly supports this combination: A 2001 study demonstrated that when nicorandil was added to continuous nitroglycerin infusion, it significantly increased coronary blood flow in both normal (+54.6%) and stenotic (+89.6%) coronary arteries, whereas additional nitroglycerin actually decreased flow 5. This suggests nicorandil provides additive benefit even during ongoing nitrate therapy.

Guideline-Based Treatment Algorithm

First-Line Therapy

  • Beta-blockers are the preferred initial antianginal agent 6
  • Sublingual nitroglycerin for acute symptom relief 6

Second-Line: Add Long-Acting Nitrates or Nicorandil

When beta-blockers alone are insufficient, guidelines recommend:

  • Long-acting nitrates (isosorbide mononitrate or dinitrate) can be added to beta-blockers 6
  • Nicorandil should be considered as add-on therapy when symptoms remain inadequately controlled 7, 8

The 2024 ESC guidelines specifically state that nicorandil may be considered as add-on therapy in patients with inadequate control while on beta-blockers and/or calcium channel blockers 7.

Practical Combination Strategy

For patients on long-acting nitrates with persistent symptoms:

  • Adding nicorandil is reasonable and supported by evidence 5
  • Nicorandil can be started at 5 mg twice daily and uptitrated 8
  • Continue sublingual nitroglycerin for acute attacks 9

For patients with heart failure and angina:

  • The 2012 ESC Heart Failure guidelines note nicorandil may be considered, though they rate the safety evidence as uncertain (Class IIb, Level C) 10
  • In this population, be more cautious with the combination

Critical Considerations and Pitfalls

Nitrate Tolerance

  • Major concern: Continuous nitrate exposure (>10-12 hours daily) causes tolerance 2, 11, 9
  • Solution: Ensure a nitrate-free interval of 10-12 hours daily with long-acting nitrate formulations 11
  • Nicorandil's K-ATP channel activity may provide benefit during nitrate-free intervals 3, 4

Hypotension Risk

  • Both drugs cause vasodilation; monitor blood pressure carefully 9
  • Avoid if systolic BP <90 mmHg or >30 mmHg below baseline 2
  • Patients should sit when taking sublingual nitroglycerin to prevent falls 9

Contraindications to Consider

  • Absolute: Recent phosphodiesterase-5 inhibitor use (sildenafil within 24h, tadalafil within 48h) 2, 9
  • Relative: Hypertrophic cardiomyopathy (nitrates may worsen angina) 9

Drug-Specific Adverse Effects

  • Nitroglycerin: Headache, dizziness, tolerance 9
  • Nicorandil: Generally well-tolerated; 11.7% adverse event rate in clinical trials 12

Evidence Quality Assessment

The combination strategy is supported by:

  • Guideline consensus from multiple societies (ACC/AHA, ESC) recommending both agents as second-line options 6, 7
  • Direct mechanistic evidence showing additive coronary blood flow effects 5
  • Clinical trial data demonstrating nicorandil reduces ischemic attacks when added to standard therapy 12

Important limitation: The 2012 ESC Heart Failure guidelines note that safety data for nicorandil in heart failure patients is uncertain 10, so exercise additional caution in this subgroup.

Practical Implementation

  1. Start with beta-blocker + sublingual nitroglycerin as needed
  2. If symptoms persist, add long-acting nitrate with proper nitrate-free interval
  3. If still inadequate control, add nicorandil (5 mg BID, uptitrate as tolerated) 8
  4. Monitor for hypotension, headache, and symptom improvement
  5. Consider revascularization if angina persists despite two antianginal drugs 10

The combination is not only safe but potentially advantageous given the complementary mechanisms and evidence of additive coronary blood flow effects 5, 3, 4.

References

Research

Vasodilator Therapy: Nitrates and Nicorandil.

Cardiovascular drugs and therapy, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.